 |
|
|
| |
INSTI In-class Switching on Continued Viral Suppression in the OPERA Cohort
|
| |
| |
Reported by Jules Levin
CROI 2016 Feb 22-14 Boston
Michael Wohlfeiler1, Felix Carpio2, Phil Lackey3, Cassidy Henegar4, Jennifer Fusco5, Michele Jonsson Funk6, Edward Vonesh7, Edwin DeJesus8, Gregory Fusco9, and Anthony Mills10
1 AIDS Healthcare Foundation, Los Angeles, CA; 2 Altamed Health Services, Los Angeles, CA; 3 Carolinas Healthcare System, Charlotte, NC; 4 Epividian, Inc., Durham, NC; 5 Epividian, Inc., Libertyville, IL; 6 Department of Epidemiology, University of North Carolina, Chapel Hill, NC;
7 Department of Preventive Medicine, Northwestern University, Chicago, IL; 8 Orlando Immunology Center, Orlando, FL; 9 OPERA Clinical and Epidemiological Advisory Board, Durham, NC; 10 Southern California Men's Medical Group, Los Angeles, CA
|
| |
|
|
|
|
|
